Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 399

1.

Barrett's oesophagus: from metaplasia to dysplasia and cancer.

Fléjou JF.

Gut. 2005 Mar;54 Suppl 1:i6-12. Review.

2.

Barrett's oesophagus--a pathologist's view.

Fléjou JF, Svrcek M.

Histopathology. 2007 Jan;50(1):3-14. Review.

PMID:
17204017
3.

Molecular evaluation of ablative therapy of Barrett's oesophagus.

Hage M, Siersema PD, Vissers KJ, Steyerberg EW, Haringsma J, Kuipers EJ, van Dekken H.

J Pathol. 2005 Jan;205(1):57-64.

PMID:
15586364
4.

Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma.

Beilstein M, Silberg D.

Gastroenterol Clin North Am. 2002 Jun;31(2):461-79, ix. Review.

PMID:
12134613
5.

Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy.

Odze RD, Lauwers GY.

Endoscopy. 2008 Dec;40(12):1008-15. doi: 10.1055/s-0028-1103416. Epub 2008 Dec 8. Review.

PMID:
19065484
6.

Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.

Werther M, Saure C, Pahl R, Schorr F, Rüschoff J, Alles JU, Heinmöller E.

Pathol Res Pract. 2008;204(5):285-94. doi: 10.1016/j.prp.2007.12.011. Epub 2008 Mar 11.

PMID:
18337019
7.
8.

K-ras point mutations are rare events in premalignant forms of Barrett's oesophagus.

Trautmann B, Wittekind C, Strobel D, Meixner H, Keymling J, Gossner L, Ell C, Hahn EG.

Eur J Gastroenterol Hepatol. 1996 Aug;8(8):799-804.

PMID:
8864678
9.

Cancer risk in Barrett's oesophagus.

Dias Pereira A, Suspiro A, Chaves P.

Eur J Gastroenterol Hepatol. 2007 Nov;19(11):915-8.

PMID:
18049157
10.

Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation.

Chinyama CN, Marshall RE, Owen WJ, Mason RC, Kothari D, Wilkinson ML, Sanderson JD.

Histopathology. 1999 Dec;35(6):517-24.

PMID:
10583575
11.

Non-goblet cell population of Barrett's esophagus: an immunohistochemical demonstration of intestinal differentiation.

Chaves P, Cardoso P, de Almeida JC, Pereira AD, Leitao CN, Soares J.

Hum Pathol. 1999 Nov;30(11):1291-5.

PMID:
10571507
12.

[DNA cytometric studies of Barrett mucosa].

Spiethoff A, Jakobs R, Martin WR, Riemann JF, Bohrer MH.

Med Klin (Munich). 2001 Apr 15;96(4):208-11. German.

PMID:
11370602
13.

Barrett's esophagus: a retrospective analysis of 13 years surveillance.

Switzer-Taylor V, Schlup M, Lübcke R, Livingstone V, Schultz M.

J Gastroenterol Hepatol. 2008 Sep;23(9):1362-7. doi: 10.1111/j.1440-1746.2008.05311.x. Epub 2008 Jan 17.

PMID:
18205769
14.

Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.

Yamamoto S, Kijima H, Hara T, Chino O, Shimada H, Tanaka M, Inokuchi S, Makuuchi H.

Int J Mol Med. 2005 Sep;16(3):375-80.

PMID:
16077942
15.

Barrett's oesophagus: microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence.

Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Weber JL, Russell SE.

Genes Chromosomes Cancer. 1998 Jan;21(1):49-60.

PMID:
9443041
16.

Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.

Sikkema M, Kerkhof M, Steyerberg EW, Kusters JG, van Strien PM, Looman CW, van Dekken H, Siersema PD, Kuipers EJ.

Am J Gastroenterol. 2009 Nov;104(11):2673-80. doi: 10.1038/ajg.2009.437. Epub 2009 Jul 28.

PMID:
19638963
17.

Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort.

Lomo LC, Blount PL, Sanchez CA, Li X, Galipeau PC, Cowan DS, Ayub K, Rabinovitch PS, Reid BJ, Odze RD.

Am J Surg Pathol. 2006 Apr;30(4):423-35.

PMID:
16625087
18.

Phenotypic differences between esophageal and gastric intestinal metaplasia.

Piazuelo MB, Haque S, Delgado A, Du JX, Rodriguez F, Correa P.

Mod Pathol. 2004 Jan;17(1):62-74.

19.

Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus.

Halm U, Tannapfel A, Breitung B, Breidert M, Wittekind CW, Mössner J.

Hepatogastroenterology. 2000 Jul-Aug;47(34):962-6.

PMID:
11020858
20.

Differential expression of the MAD2, BUB1 and HSP27 genes in Barrett's oesophagus-their association with aneuploidy and neoplastic progression.

Doak SH, Jenkins GJ, Parry EM, Griffiths AP, Baxter JN, Parry JM.

Mutat Res. 2004 Mar 22;547(1-2):133-44.

PMID:
15013707

Supplemental Content

Support Center